CO108 Subgroup Analysis of Quality of Life and Treatment Satisfaction By Disease Duration and Use of PRIOR Treatment: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo
Abstract
Authors
K Ezzedine N van Geel K Butler K Bibeau J Gao AG Pandya